Global Cord Blood Corporation (NYSE:CO) stock identified change of -4.17% away from 52-week low price and recently located move of -40.49% off 52-week high price. It has market worth of $575.32M and dividend yield of 1.74%. CO stock has been recorded -18.46% away from 50 day moving average and -27.51% away from 200 day moving average. Moving closer, we can see that shares have been trading -16.82% off 20-day moving average.
On Aug. 27, 2019, Global Cord Blood Corporation (NYSE:CO) China’s leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, released its unaudited financial results for the first quarter of fiscal 2020 ended June 30, 2019.
First Quarter of Fiscal 2020 Highlights
- Revenues increased by 16.9% year-over-year (YoY) to RMB273.4 million ($39.8 million).
- New subscribers and accumulated subscriber base were 20,815 and 770,699[1], respectively.
- Gross profit increased by 19.4% YoY to RMB227.6 million ($33.2 million). Gross margin improved to 83.3% from 81.5% in the prior year period.
- Operating income increased by 17.8% YoY to RMB112.4 million ($16.4 million).
- Operating income before depreciation and amortization [2] (non-GAAP operating income) increased by 15.0% YoY to RMB124.8 million ($18.2 million).
- Net income attributable to the Company’s shareholders increased significantly by 47.3% YoY to RMB108.3 million ($15.8 million) as a result of improved operating income and an increase in fair value of equity securities (mark-to-market gains) of RMB10.0 million ($1.5 million) in the first quarter.
During the first quarter of fiscal 2020, even though macro-economic uncertainty continued to pressure consumer spending on preventive healthcare services, we managed to record 20,815 new subscribers, in line with our expectations, said Ms. Ting Zheng, Chairperson and Chief Executive Officer of GCBC. As we step into a more economically volatile fiscal year, we will remain alert to the market changes as well as any potential developments in the regulatory regime governing the cord blood banking industry in China. We will strive to expand service offerings and may mitigate business concentration risk through acquisitions in addition to increasing our penetration and business expansion.
The Healthcare sector company, Global Cord Blood Corporation noticed change of -7.44% to $4.6 along volume of 227203 shares in recent session compared to an average volume of 63.37K. The stock observed return of -15.13% in 5 days trading activity. The stock was at -18.00% over one month performance. CO’s shares are at -27.90% for the quarter and driving a -30.20% return over the course of the past year and is now at -28.68% since this point in 2018. The average volatility for the week at 8.39% and for month was at 4.33%. There are 125.07M shares outstanding and 34.65M shares are floated in market. Right now the stock beta is 0.13.
Timothy Bowers is a stock trader and Analyst writer. His current focus is top trending News. He scans the wall street market and then cover the top trending stock. In addition to content writing, Timothy is an SEO Expert and Digital marketer. He has the expertise to deliver a wide range of projects and the experience to understand the quality of work required.
Address: 1884 Hopkins Landing Road, Quincy, FL 32351, USA
Email: Timothy@shopordered.com
Zip Code: 32351
Phone Number: 850-655-1866
